Publications by authors named "Angel Cedillo"

Claim this Profile
F
Frailty dynamics and their impact on QoL in patients undergoing autologous HCT for multiple myeloma: Results from a multicentre GETH-TC study.
Carles Tolosa-Ridao, Mónica Baile González, Marina Acera Gómez, Laura Fox, María Del Mar Pérez Artigas, Ángel Cedillo

Br J Haematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-infections during SARS-CoV-2 infection in hematologic patients and cell therapy recipients in the omicron era: a Spanish hematopoietic stem cell transplantation and cell therapy group study.
Pedro Chorão, Alex Avendaño, Inmaculada Heras, Francesco Aiello, Mireia Micó-Cerdá, Ángel Cedillo

BMC Infect Dis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frailty assessment in adults undergoing allogeneic hematopoietic cell transplantation: insights from a multicenter GETH-TC study to optimize outcomes and care.
María Queralt Salas, María Teresa Solano, Mónica Baile González, Marina Acera Gómez, Laura Fox, Ángel Cedillo

Front Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac events occurring after allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide. Study conducted on behalf of the GETH-TC.
María Queralt Salas, Enric Cascos, Alberto López-García, Estefanía Pérez-López, Mónica Baile-González, Ángel Cedillo

Bone Marrow Transplant· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac events after allo-HCT in patients with acute myeloid leukemia.
María Queralt Salas, Enric Cascos, Alberto López-García, Estefanía Pérez, Mónica Baile-González, Ángel Cedillo

Blood Adv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on Cytomegalovirus Infection Management in Allogeneic Hematopoietic Stem Cell Transplant Recipients. A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC).
José Luis Piñana, Estela Giménez, Lourdes Vázquez, María Ángeles Marcos, Manuel Guerreiro, Angel Cedillo

Mediterr J Hematol Infect Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy.
José Luis Piñana, Lourdes Vazquez, Inmaculada Heras, Tommaso Francesco Aiello, Lucia López-Corral, Ángel Cedillo

Front Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant.
Joaquín Martínez-López, Javier de la Cruz, Rodrigo Gil-Manso, Víctor Jiménez Yuste, José María Aspa-Cilleruelo, Ángel Cedillo

Cancers (Basel)· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients.
José Luis Piñana, Inmaculada Heras, Tommaso Francesco Aiello, Irene García-Cadenas, Lourdes Vazquez, Ángel Cedillo

Viruses· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: a survey-based study.
Carlos Solano, Pedro Castro-Rebollo, Antonio Pérez-Martínez, Lucia López-Corral, Pere Barba-Suñol, Ángel Cedillo

BMJ Open· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE).
Riccardo Saccardi, Hein Putter, Dirk-Jan Eikema, María Paula Busto, Eoin McGrath, Ángel Cedillo

Bone Marrow Transplant· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2-reactive antibody waning, booster effect and breakthrough SARS-CoV-2 infection in hematopoietic stem cell transplant and cell therapy recipients at one year after vaccination.
José Luis Piñana, Rodrigo Martino, Lourdes Vazquez, Lucia López-Corral, Ariadna Pérez, Ángel Cedillo

Bone Marrow Transplant· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study.
Joaquín Martínez-López, Javier De la Cruz, Rodrigo Gil-Manso, Adrián Alegre, Javier Ortiz, Ángel Cedillo

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients.
José Luis Piñana, Lourdes Vazquez, Marisa Calabuig, Lucia López-Corral, Gabriel Martin-Martin, Ángel Cedillo

Blood Cancer J· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patients.
José Luis Piñana, Pablo Rodríguez-Belenguer, Dolores Caballero, Rodrigo Martino, Lucia Lopez-Corral, Ángel Cedillo

Ann Hematol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders.
José Luis Piñana, Lucia López-Corral, Rodrigo Martino, Lourdes Vazquez, Ariadna Pérez, Ángel Cedillo

J Hematol Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients.
José Luis Piñana, Lourdes Vázquez, Rodrigo Martino, Rafael de la Cámara, Anna Sureda, Ángel Cedillo

Leuk Lymphoma· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2-reactive antibody detection after SARS-CoV-2 vaccination in hematopoietic stem cell transplant recipients: Prospective survey from the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group.
José Luis Piñana, Lucia López-Corral, Rodrigo Martino, Juan Montoro, Lourdes Vazquez, Angel Cedillo

Am J Hematol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19.
José Luis Piñana, Ramon Garcia-Sanz, Rodrigo Martino, María Garcia-Roa, Gabriel Andrés Martin-Martin, Ángel Cedillo

Blood Adv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey.
Per Ljungman, Rafael de la Camara, Malgorzata Mikulska, Gloria Tridello, Beatriz Aguado, Angel Cedillo

Leukemia· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.
Julio García-Suárez, Javier de la Cruz, Ángel Cedillo, Pilar Llamas, Rafael Duarte

J Hematol Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors and outcome of COVID-19 in patients with hematological malignancies.
José Luis Piñana, Rodrigo Martino, Irene García-García, Rocío Parody, María Dolores Morales, Angel Cedillo

Exp Hematol Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis.
Carlos Vallejo, Pau Montesinos, Marta Polo, Beatriz Cuevas, Marta Morado, Ángel Cedillo

Ann Hematol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis